Peripheral arterial disease pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 37: Line 37:
===Associated Disorders===
===Associated Disorders===
Many PVD patients also have [[angina pectoris]] or have had [[myocardial infarction]]. There is also an increased risk for [[stroke]].
Many PVD patients also have [[angina pectoris]] or have had [[myocardial infarction]]. There is also an increased risk for [[stroke]].
The moderate consumption of alcohol has been found to be associated with a reduction of the risk of PVD by almost one-third compared to those who do not drink alcohol.<ref>{{cite journal |author=Camargo CA, Stampfer MJ, Glynn RJ, ''et al'' |title=Prospective study of moderate alcohol consumption and risk of peripheral arterial disease in US male physicians |journal=Circulation |volume=95 |issue=3 |pages=577–80 |year=1997 |month=February |pmid=9024142 |url=http://circ.ahajournals.org/cgi/content/full/95/3/577}}</ref>


==References==
==References==

Revision as of 23:57, 30 October 2012

Peripheral arterial disease Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Peripheral arterial disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Guidelines for Management

Case Studies

Case #1

AHA/ACC Guidelines on Management of Lower Extremity PAD

Guidelines for Clinical Assessment of Lower Extremity PAD

Guidelines for Diagnostic Testing for suspected PAD

Guidelines for Screening for Atherosclerotic Disease in Other Vascular Beds in patients with Lower Extremity PAD

Guidelines for Medical Therapy for Lower Extremity PAD

Guidelines for Structured Exercise Therapy for Lower Extremity PAD

Guidelines for Minimizing Tissue Loss in Lower Extremity PAD

Guidelines for Revascularization of Claudication in Lower Extremity PAD

Guidelines for Management of CLI in Lower Extremity PAD

Guidelines for Management of Acute Limb Ischemial in Lower Extremity PAD

Guidelines for Longitudinal Follow-up for Lower Extremity PAD

Peripheral arterial disease pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Peripheral arterial disease pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Peripheral arterial disease pathophysiology

CDC on Peripheral arterial disease pathophysiology

Peripheral arterial disease pathophysiology in the news

Blogs on Peripheral arterial disease pathophysiology

Directions to Hospitals Treating Peripheral arterial disease

Risk calculators and risk factors for Peripheral arterial disease pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

Pathophysiology

  • PAD is a manifestation of systemic atherosclerosis that has developed over many years.
  • Atherosclerosis is a complex process that involves endothelial dysfunction, lipid disturbances, platelet activation, thrombosis, oxidative stress, vascular smooth muscle activation, altered matrix metabolism, remodeling and genetic factors
  • Atherosclerosis frequently develops at arterial bifurcations and branches where endogenous atheroprotective mechanisms are impaired as a result of the effects of disturbed flow on endothelial cells
  • The stages of atherosclerosis are divided into the following:
    • Lesion initiation
      • Results from endothelial dysfunction
    • Formation of the fatty streak
      • Results from an inflammatory lesion that develops first
      • Affects the intima of the artery and leads to formation of the foam cell
      • Fatty streak consists primarily of smooth muscle cells, monocytes, macrophages, and T and B cells
    • Fibroproliferative atheroma development
      • Originates from the fatty streak
      • Contains larger numbers of smooth muscle cells frlled with lipids
    • Advanced lesion development
      • Results from continued accumulation of cells that make up the fatty streak and fibroproliferative atheroma
      • Highly cellular
      • Contains intrinsic vascular cell walls (both endothelial and smooth muscle), and inflammatory cells (monocytes, macrophages, and T lymphocytes)
      • Also contains a lipid core covered by a fibrous cap
  • Arteries initially compensate for atherosclerosis by remodeling, which causes the blood vessels to increase in size
  • Advanced lesions eventually intrude into the lumen, resultsing in flow-limiting stenoses and chronic ischemic syndromes
  • Acute arterial events occur if the fibrous cap is disrupted, the resulting exposure of the "prothrombotic" necrotic lipid core and subendothelial tissue leads to thrombus formation and flow occlusion
  • In addition to coronary artery disease and cerebrovascular disease, PAD is one of the three major syndromes of atherothrombosis
  • Atherothrombosis is the term currently used to describe the process of thrombus formation on top of a ruptured plaque located at a disease arterial segment
  • Such atherosclerotic plaques tend to occur at vessel bifurcations, presumed to be due to both impaired atheroprotective mechanisms and disturbed blood flow leading to local intimal injury
  • Panvascular disease refers to clinically significant atherosclerosis is present in multiple vascular beds
Diagram of arterial lumen (Image courtesy of Amjad Almahameed)

Associated Disorders

Many PVD patients also have angina pectoris or have had myocardial infarction. There is also an increased risk for stroke.

References


Template:WikiDoc Sources